Aurora Receives Approval for Medicinal Cannabis Product in Ireland

- December 2nd, 2019

Aurora Cannabis announced the approval for use of its products under Ireland’s new Medical Cannabis Access Programme (MCAP).

Aurora Cannabis (NYSE:ACB,TSX:ACB) announced the approval for use of its products under Ireland’s new Medical Cannabis Access Programme (MCAP).

As quoted in the press release:

Aurora’s High CBD Oil Drops received approval from the Irish authorities and have now been added to a regulatory schedule by the Irish Minister of Health enabling importation, prescribing and supply under the scheme and is to date, one of only two products to gain such authorization.

Dr Shane Morris, Chief Product Officer at Aurora said, “Aurora is pleased to be able to assist patients who are seeking treatment with high quality EU-GMP (good manufacturing practice) certified pharmaceutical-grade medical cannabis in Ireland. We are very proud to be one of the first approved suppliers of medical cannabis under the MCAP. We want to acknowledge the efforts made by many people, especially the patients and doctors who have campaigned for access to these medicines.  We look forward to more of Aurora’s high-quality medicines being approved, so that more patients can benefit from the MCAP in Ireland.  We will continue to work closely with all parties and state agencies to facilitate further availability.”

Click here to read the full press release.

Find out what experts are saying about the future of cannabis

 
Read our new report today
 

Get the latest Cannabis Investing stock information

Leave a Reply

Your email address will not be published. Required fields are marked *